title: Intravenous immunoglobulin is effective as a sole immunomodulatory agent in pyoderma gangrenosum unresponsive to systemic corticosteroids.
authors.forename: R
authors.initials: R
authors.lastname: Suchak
authors.forename: C
authors.initials: C
authors.lastname: Macedo
authors.forename: M
authors.initials: M
authors.lastname: Glover
authors.forename: F
authors.initials: F
authors.lastname: Lawlor
mesh_terms: D000369:Aged, 80 and over; D016523:Foot Ulcer / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D017511:Pyoderma Gangrenosum / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors